Traxyl 500 Injection

About Traxyl 500 500 mg/5 ml Injection

Traxyl 500 is an injection containing tranexamic acid, an anti-fibrinolytic medicine. It is used to help control bleeding in certain medical and surgical situations.

There are 35 brands of Tranexamic Acid listed in Bangladesh. The lowest listed price is Enclot 250 mg Capsule at ৳ 8.06 per unit.

What is Traxyl 500 500 mg/5 ml Injection?

Traxyl 500 is a 500 mg/5 ml injection of tranexamic acid, made by Nuvista Pharma Ltd. It belongs to a group of medicines called anti-fibrinolytic drugs. These medicines work by slowing down the breakdown of blood clots, which can help reduce bleeding. Doctors use it in various situations, such as certain types of internal bleeding, bleeding related to some blood disorders, and during or after surgery. It is given by a healthcare professional. The dose and course are decided by the doctor based on the patient's condition.

Uses of Traxyl 500

Traxyl 500 is used to prevent and treat bleeding in several medical conditions, including bleeding from the lungs or digestive tract, bleeding disorders linked to leukaemia, cirrhosis, haemophilia, and low platelets. It is also used when bleeding occurs during clot-dissolving treatment or transfusion. In surgery, it helps prevent and control bleeding during operations, especially lung and heart surgeries. Your doctor will decide if it is suitable for you.

How to use Traxyl 500

Traxyl 500 is given by injection by a healthcare professional. It can be given into a vein or a muscle, depending on the doctor's decision. The dose and how often it is given are determined by the doctor, taking into account the reason for use and the patient's condition. Do not try to inject it yourself. If you have any questions about how it is being given, ask your doctor or pharmacist.

Side effects of Traxyl 500

Traxyl 500 is generally well tolerated, but some people may experience side effects. These can include a sense of tiredness, eye irritation, nasal blockage, itching, skin redness, or a rash. After oral use, nausea, diarrhoea, and heartburn have been reported, though this injection is not taken by mouth. Rarely, a drop in blood pressure when standing may occur. If you notice any unusual symptoms, tell your doctor or nurse.

Safety and precautions

Before receiving Traxyl 500, tell your doctor if you have ever had an allergic reaction to tranexamic acid, or if you have a history of blood clots, thrombosis, or serious kidney problems. It should not be used in pregnancy unless clearly needed, and it may pass into breast milk in small amounts. Your doctor will decide if it is appropriate for you. Always ask your doctor or pharmacist if you have any concerns about precautions or interactions.

Frequently asked questions

What is Traxyl 500 used for and what kind of medicine is it?

Traxyl 500 is an anti-fibrinolytic medicine containing tranexamic acid. It helps prevent and treat bleeding in various medical and surgical situations. Your doctor will decide if it is suitable for your condition.

Which medicines may interact with Traxyl 500?

Tranexamic acid may interact with penicillins, thrombolytic drugs like streptokinase and urokinase, and estrogen-containing medicines such as oral contraceptives. It should not be mixed directly with whole blood during transfusion. Tell your doctor about all medicines you take.

How should Traxyl 500 be stored?

Store Traxyl 500 in a dry place, away from light, and keep it out of the reach of children. The recommended storage temperature is given on the packaging. Ask your pharmacist if you are unsure about the storage conditions.

Who should not receive Traxyl 500?

People with known allergy to tranexamic acid, a history of blood clots or thrombosis, or serious kidney failure should not receive it. It should not be used during pregnancy unless your doctor decides it is necessary. Always inform your doctor about your medical history.

Indications

In medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.

In surgery: Prophylaxis and antihemorrhagic ... Read moreIn medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.

In surgery: Prophylaxis and antihemorrhagic therapy during operations of any type and nature and particularly in pulmonary, cardiovascular and abdominal surgery and post-operative and traumatic shock.

In urology: Prophylaxis and antihemorrhagic therapy of prostatic, vesical and renal surgery. Hematurias.

In obstetrics: Prophylaxis and therapy of post-partum and puerperium hemorrhages, hemorrhagic metrophathies, functional menometrorrhagias, idiopathic or IUD(lntra uterine Device) induced menorrhagias, primitive hyperfibrinolysis (abruptio placentae, premature placenta detachment) and in cervical conization.

In otorhinolaryngology: Prophylaxis and antihemorrhagic therapy during a tonsillectomy, specialist surgery generally, epistaxis.

In stomatology: Prophylaxis and antihemorrhagic therapy during maxillofacial operations, tooth extractions.

In oncology (as supportive therapy): To promote the formation of a fibrin capsule to wall off and thereby inhibit the growth of ovarian tumors. To cause regression of ascites secondary to carcinoma. To reduce bleeding during surgical interventions.

Pharmacology

This is a preparation of tranexamic acid (trans-4 aminomethyl-cyclohexanecarboxylic acid). Tranexamic acid is a substance endowed with a strong antifibrinolytic action and both in vivo and in vitro it has proved to be 10 times more active than conventional hemostatics, depending on the test. The antihemorrhagic action of tranexamic acid is essentially due to an inhibition of the plasminogen activation of both exogenous activators like streptokinase and endogenous ones like urokinase and the plasminogen tissue activator. This fact is particularly important for the clinical use of Tranexamic Acid, because it ensures an antihemorrhagic activity with an antifibrinolytic mechanism under a variety of conditions.

The acute toxicity of Tranexamic Acid is extremely low and chronic toxicity almost non-existent. Tranexamic Acid is well absorbed by oral route and the effect is already seen 15-30 minutes after administration. It is excreted mainly by renal route but more slowly than conventional hemostatics. These features make the Tranexamic Acid effect more lasting than those conventional hemostatics. Considerably lower single doses of Tranexamic Acid can thus be administered at greater intervals without the drug plasma levels dropping to inefficient levels of antifibrinolytic activity between one dose and the other.

Tranexamic Acid at therapeutic doses does not interfere with clotting processes and even a prolonged administration has not been seen to be accompanied by any tendency to thrombophilia.

Dosage & Administration

Adults-
  • The usual dose: 500-1000 mg 3 times daily.
  • For prophylaxis: The mean recommended daily doses are 0.5-1 gm orally, 500 mg by the parenteral (intravenous or intramuscular) route.
  • For therapy of hemorrhagic manifestations: the oral dose increases to 1-3 gm given in divided doses: in cases of particular seriousness and urgency, begin by injecting an ampoule (500 mg) slowly by intravenous route and administer the necessary subsequent oral doses.
Children-
  • For prophylaxis: For every kg of body weight from 5-10 mg are orally administered daily in divided doses.
  • For therapeutic purposes: The oral doses are doubled (from 10 to 20 mg/kg), while the intravenous and intramuscular treatment is begun with 10 mg/kg (=0.5 ml every 5 kg) by the slow intravenous route, continuing the oral administration up to the required dose. Where it is more convenient (e.g. in small babies) the ampoules, diluted in a little sweetened water, maybe orally administered instead of the Capsules.
Elderly patients: No reduction in dosage is necessary unless there is evidence of renal failure.

Interaction

Tranexamic Acid is a synthetic Amino Acid that is incompatible with solutions containing penicillins (eg: Benzyl penicillin). Thrombolytic drugs like Streptokinase & Urokinase antagonise the antifibrinolytic action of Tranexamic Acid. The potential for thrombus formation may be increased by concomitant administration of estrogen containing drugs, like oral contraceptives. Direct admixture of Tranexamic Acid with whole blood should be avoided during Transfusion.

Contraindications

Known individual hypersensitivity to the product. Thromboembolic disease, arterial and venous thrombosis, endocavitary hemorrhages, serious kidney failure.

Side Effects

  • Tranexamic Acid is generally well tolerated; there may be infrequent cases of sense of fatigue, conjunctival irritation, nasal blockage, itching, skin reddening, exanthems.
  • After oral administration there may be sign of nausea, diarrhea, gastric pyrosis.
  • There are rare cases of postural hypotension.
  • In the case of hypersensitivity to tranexamic acid, avoid or suspend treatment and start a suitable therapy.

Pregnancy & Lactation

Since the transplacental passage of the drug and its possible effects on the fetus are unknown, Tranexamic Acid should not be administered during known and presumed pregnancy. Tranexamic Acid passes into breast milk to a concentration of approximately one hundredth of the concentration in the maternal blood. An antifibrinolytic effect in the infant is unlikely.

Precautions & Warnings

  • Tranexamic Acid should be used in cases where there is hyperfibrinolysis. The prophylactic treatment must begin 24 hours before the operation and continue until 3-4 days after it.
  • The therapy of hemorrhages must be prolonged for at least 24 hours after manifestations have disappeared.
  • In hematuria, especially when this is not accompanied by any other hemorrhagic manifestations, reduce the doses to prevent formation of clots in the urinary tract.
  • Tranexamic Acid must not be used in serious renal insufficiency or anuric syndromes and must only be used with caution in less serious renal dysfunctions.
  • The administration of product requires particular care in cardiopathic and hepatopathic subjects.

Storage Conditions

Store in a dry place at 15-30°C, away from light and keep out of children's reach.

Alternative brands of Tranexamic Acid

Other brands with the same generic name, cheapest first.

Anaxyl Capsule

500 mg

Tranexamic Acid

Advanced Chemical Industries PLC

৳ 19.66 ৳ 20.06 2% off per unit

Anaxyl Tablet

500 mg

Tranexamic Acid

Advanced Chemical Industries PLC

৳ 19.66 ৳ 20.06 2% off per unit

See all 35 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.